# FDA Inspection 1128993 - David R. Spigel, M.D. - August 25, 2020

Source: https://www.keypedia.com/records/fda_inspections/david-r-spigel-md/3fd1eea3-1f6f-4d8b-a54e-228f435127ed
Source feed: FDA_Inspections

> FDA Inspection 1128993 for David R. Spigel, M.D. on August 25, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1128993
- Company Name: David R. Spigel, M.D.
- Inspection Date: 2020-08-25
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1147799 - 2021-06-28](https://www.keypedia.com/records/fda_inspections/david-r-spigel-md/324417d9-3739-4150-b28a-889c5df0ef22)
- [FDA Inspection 757125 - 2011-11-02](https://www.keypedia.com/records/fda_inspections/david-r-spigel-md/6c3eb4ce-157e-46fa-b711-c720adf9b1c3)

Company: https://www.keypedia.com/companies/david-r-spigel-md/3d502a0c-cd61-4741-a78f-4ed259e9e49e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c